Skip to main content
Premium Trial:

Request an Annual Quote

MTI-GlobalStem’s PluriQ G9 Gene Editing System

MTI-GlobalStem has launched its PluriQ G9 gene editing system. It includes the G9 Maintenance medium G9 VTN Recombinant (vitronectin) plate coating, EditPro Stem Transfection reagent, and G9 Versene solution. The system is used for culturing human pluripotent stem cells to maximize transfection of genome editing constructs, up to 90 percent efficiency, the company said. The EditPro Stem can be used to deliver DNA, mRNA, and/or protein giving the researcher flexibility in experimental design. It is also optimized for CRISPR/Cas9 editing.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.